AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $689 | -14.6% | 27,863 | -1.7% | 0.00% | 0.0% |
| Q2 2023 | $807 | +37.7% | 28,331 | +11.2% | 0.00% | +100.0% |
| Q1 2023 | $586 | -16.6% | 25,483 | +2.2% | 0.00% | -50.0% |
| Q4 2022 | $703 | -99.8% | 24,933 | +121.5% | 0.00% | +100.0% |
| Q3 2022 | $318,000 | +367.6% | 11,258 | +263.0% | 0.00% | – |
| Q2 2022 | $68,000 | -25.3% | 3,101 | +5.1% | 0.00% | – |
| Q1 2022 | $91,000 | -1.1% | 2,950 | +5.0% | 0.00% | – |
| Q4 2021 | $92,000 | -39.5% | 2,809 | -14.0% | 0.00% | – |
| Q3 2021 | $152,000 | -27.3% | 3,265 | -14.1% | 0.00% | – |
| Q2 2021 | $209,000 | +7.7% | 3,799 | 0.0% | 0.00% | – |
| Q1 2021 | $194,000 | +14.1% | 3,799 | -3.3% | 0.00% | – |
| Q4 2020 | $170,000 | +24.1% | 3,928 | 0.0% | 0.00% | – |
| Q3 2020 | $137,000 | -34.4% | 3,928 | 0.0% | 0.00% | – |
| Q2 2020 | $209,000 | +48.2% | 3,928 | 0.0% | 0.00% | – |
| Q1 2020 | $141,000 | -24.2% | 3,928 | 0.0% | 0.00% | – |
| Q4 2019 | $186,000 | -45.8% | 3,928 | -43.0% | 0.00% | -100.0% |
| Q2 2019 | $343,000 | -33.7% | 6,893 | -10.3% | 0.00% | 0.0% |
| Q1 2019 | $517,000 | +75.9% | 7,685 | +16.5% | 0.00% | 0.0% |
| Q4 2018 | $294,000 | -31.3% | 6,599 | +19.1% | 0.00% | 0.0% |
| Q3 2018 | $428,000 | -8.4% | 5,543 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $467,000 | +2.9% | 5,543 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $454,000 | +43.7% | 5,543 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $316,000 | -12.0% | 5,543 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $359,000 | +26.0% | 5,543 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $285,000 | +62.9% | 5,543 | +84.6% | 0.00% | – |
| Q1 2017 | $175,000 | +38.9% | 3,002 | 0.0% | 0.00% | – |
| Q4 2016 | $126,000 | -60.1% | 3,002 | -50.0% | 0.00% | – |
| Q3 2016 | $316,000 | +152.8% | 6,004 | +100.0% | 0.00% | – |
| Q2 2016 | $125,000 | +2.5% | 3,002 | 0.0% | 0.00% | – |
| Q1 2016 | $122,000 | +4.3% | 3,002 | +66.8% | 0.00% | – |
| Q4 2015 | $117,000 | -7.9% | 1,800 | 0.0% | 0.00% | – |
| Q3 2015 | $127,000 | -36.5% | 1,800 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $200,000 | +18.3% | 1,800 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $169,000 | -15.9% | 1,800 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $201,000 | +35.8% | 1,800 | -25.0% | 0.00% | – |
| Q3 2014 | $148,000 | +34.5% | 2,400 | 0.0% | 0.00% | – |
| Q2 2014 | $110,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |